Forever Princess by Meg Cabot Read Free Book Online Page B

dad will always be able to get his plays produced.
    But anyway, none of that is what I’m freaking out about. It’s what happened afterward.
    It was after Grandmère had harangued me some more about the invitation list to my party—and said to Mr. G, “Do your niece and nephew have to attend? Because youknow if I could scratch them off I could make room for the Beckhams”—and then finally hung up that Dad said, “I think you ought to show it to her now,” and Mom said, “Really, Phillipe, I think you’re being just a tad dramatic, there’s no need for you to stay on the phone, I’ll give it to her later,” and Dad said, “I’m part of this family, too, and I want to be here to support her, even if I can’t actually be there in the flesh,” and Mom said, “You’re overreacting. But if you insist,” and she got up and went into her room.
    And I went, starting to feel a bit nervous, “What’s going on?”
    And Mr. G said, “Oh, nothing. Your dad just e-mailed something he saw on international business CNN.”
    â€œAnd I want you to see it, Mia,” Dad said, through the speakerphone, “before someone tells you about it at school.”
    And my heart sank, because I figured it was some new scheme of René’s to junk up Genovia in order to get more tourists to go there. Maybe he was going to put a Hard Rock Cafe in there, and try to get Clay Aiken to come and play at its grand opening.
    Only it wasn’t. When Mom came out of her bedroom with a printout of what Dad e-mailed her, I saw that it had nothing to do with René at all.
    It was this:
    NEW YORK (AP)—Robotic arms are the future for surgery, and one in particular, dubbed the CardioArm, will be revolutionizing cardiac surgery, already making its creator—MichaelMoscovitz, 21, of Manhattan—a very wealthy man.
    His invention is being billed as the first surgical robot compatible with advanced imaging technology. Moscovitz spent two years leading a team of Japanese scientists designing CardioArm for his small company, Pavlov Surgical.
    The stock of Pavlov Surgical, Moscovitz’s high-tech company with a monopoly on selling robotic surgical arms in the United States, has surged nearly 500 percent over the last year. Analysts believe that the rally is far from over.
    That’s because demand for Moscovitz’s product is growing, and so far his small company has the market all to itself.
    The surgical arm, which is controlled remotely by surgeons, was approved by the Food and Drug Administration for general surgery last year.
    The CardioArm system is considered to be more precise and less invasive than traditional surgical tools that include small handheld surgical cameras inserted into the body during surgery. Recovery from surgery performed by the CardioArm system is considerably faster than recovery from traditional surgery.
    â€œWhat you can do with the robotic arm—with the capabilities in manipulation and visualization—you just can’t do any other way,” said Dr. Arthur Ward, head of cardiology at Columbia University Medical Center.
    There are already 50 CardioArms operating inAmerican hospitals, with a waiting list of hundreds more, but with a price tag ranging from $1 million to $1.5 million, the systems don’t come cheap. Moscovitz has donated several CardioArm systems to children’s hospitals nationwide, and will be donating a new one to Columbia University Medical Center this weekend, a fact for which the university, his alma mater, is grateful.
    â€œThis is a highly perfected, highly sought-after, very unique technology,” said Ward. “In terms of robotics, CardioArm is the clear leader. Moscovitz has done something extraordinary for the field of surgical medicine.”
    !!!!!!!!!!
    Wow. The ex-girlfriend is always the last to know.
    But whatever. It’s not like this changes anything.
    I